Abstract
We have transfected murine neural stem cells (NSCs) and rat umbilical cord matrix-derived stem cells (RUCMSCs) with a plasmid expressing gaussia luciferase (gLuc). These cells are engineered to secrete the luciferase. We have used gLuc containing supernatant from culturing the NSCs to perform in vitro photodynamic therapy of murine melanoma cells (B16F10), and RUCMSCs to perform in vivo PDT of lung melanomas in C57BL/6 mice. The treatment system was comprised of aminolevulic acid as a prodrug for the synthesis of the photosensitizer protoporphyrin IX, gaussia luciferase, and its’ substrate coelenterazine. A significant reduction of the number of live melanoma cells in vitro and a borderline significant retardation of tumour growth in vivo was observed after coelenterazine-mediated PDT.
Similar content being viewed by others
Notes and references
S. Marchini, M. D’Incalci and M. Broggini, New molecules and strategies in the field of anticancer agents, Curr. Med. Chem.: Anti-Cancer Agents, 2004, 4, 247–262.
D. E. Dolmans, D. Fukumura and R. K. Jain, Photodynamic therapy for cancer, Nat. Rev. Cancer, 2003, 3, 380–387.
U.S. Food and Drug Administration (December 2003). Approved claims for palliative line therapy. Retrieved December 29, 2003, from: http://www.accessdata.fda.gov.
J. Strasswimmer and D. J. Grande, Do pulsed lasers produce an effective photodynamic therapy response?, Lasers Surg. Med., 2006, 38, 22–25.
H. Tanaka, K. Hashimoto, I. Yamada, K. Masumoto, T. Ohsawa, M. Murai and T. Hirano, Interstitial photodynamic therapy with rotating and reciprocating optical fibers, Cancer, 2001, 91, 1791–1796.
H. Lui, L. Hobbs, W. D. Tope, P. K. Lee, C. Elmets, N. Provost, A. Chan, H. Neyndorff, X. Y. Su, H. Jain, I. Hamzavi, D. McLean and R. Bissonnette, Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes, Arch. Dermatol., 2004, 140, 26–32.
K. E. Borbas and D. Lahaye, Photodynamic therapy of cancer, in Anticancer therapeutics, ed. S. Missailidis, John Wiley & Sons, Ltd, 2008, pp. 187–222.
Y. Yu, T. Timiryasova, Q. Zhang, R. Beltz and A. Szalay, Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals, Anal. Bioanal. Chem., 2003, 377, 964–972.
S. Das, A. M. Powe, G. A. Baker, B. Valle, B. El-Zahab, H. O. Sintim, M. Lowry, S. O. Fakayode, M. E. McCarroll, G. Patonay, M. Li, R. M. Strongin, M. L. Geng and I. M. Warner, Molecular fluorescence, phosphorescence, and chemiluminescence spectrometry, Anal. Chem., 2012, 84, 597–625.
C. Zong, J. Wu, C. Wang, H. Ju and F. Yan, Chemiluminescence imaging immunoassay of multiple tumor markers for cancer screening, Anal. Chem., 2012, 84, 2410–2415.
Y. Yu, T. Timiryasova, Q. Zhang, R. Beltz and A. Szalay, Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals, Anal. Bioanal. Chem., 2003, 377, 964–972.
B. A. Tannous and J. Teng, Secreted blood reporters: insights and applications, Biotechnol. Adv., 2011, 29, 997–1003.
M. L. Dubuisson, J. F. Rees, J. Marchand-Brynaert, Coelenterazine (marine bioluminescent substrate): a source of inspiration for the discovery of novel antioxidants, Drug Dev. Ind. Pharm., 2005, 31, 827–849.
B. Zhao, Y.-Y. He, Recent advances in the prevention and treatment of skin cancer using photodynamic therapy, Expert Rev. Anticancer Ther., 2010, 10, 1797–1809.
J. Morgan and A. R. Oseroff, Mitochondria-based photodynamic anti-cancer therapy, Adv. Drug Delivery Rev., 2001, 49, 71–86.
H. C. Hatcher, R. N. Singh, F. M. Torti and S. V. Torti, Synthetic and natural iron chelators: therapeutic potential and clinical use, Future Med. Chem., 2009, 1, 1643–1670.
T. Theodossiou, J. S. Hothersall, E. A. Woods, K. Okkenhaug, J. Jacobson and A. J. MacRobert, Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 Cells, Cancer Res., 2003, 63, 1818–1821.
A. Roda, M. Guardigli, E. Michelini and M. Mirasoli, Nanobioanalytical luminescence: Förster-type energy transfer methods, Anal. Bioanal. Chem., 2009, 393, 109–123.
M. Morisaki, J. Rubio-Lightbourn and N. Ikekawa, 1. Steroids. V. Synthesis of active forms of vitamin D. I. facile synthesis of 25-hydroxycholesterol full text, Chem. Pharm. Bull., 1973, 21, 457–458.
S. H. Mousavi, J. Tavakkol-Afshari, A. Brook, I. Jafari-Anarkooli, Direct toxicity of rose bengal in MCF-7 cell line: role of apoptosis, Food Chem. Toxicol., 2009, 47, 855–859.
R. S. Rachakatla, S. Balivada, G. M. Seo, C. B. Myers, H. Wang, T. N. Samarakoon, R. Dani, M. Pyle, F. O. Kroh, B. Walker, X. Leaym, O. B. Koper, V. Chikan, S. H. Bossmann, M. Tamura and D. L. Troyer, Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells, ACS Nano, 2010, 4, 7093–7104.
M. T. Basel, S. Balivada, H. Wang, T. B. Shrestha, G. M. Seo, M. Pyle, G. Abayaweera, R. Dani, O. B. Koper, M. Tamura, V. Chikan, S. H. Bossmann and D. L. Troyer, Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model, Int. J. Nanomed., 2012, 7, 297–306.
G. M. Seo, R. S. Rachakatla, S. Balivada, M. Pyle, T. B. Shrestha, M. T. Basel, C. Myers, H. Wang, M. Tamura, S. H. Bossmann and D. L. Troyer, A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma, Mol. Biol. Rep., 2012, 39, 157–165.
M. T. Basel, S. Balivada, T. B. Shrestha, G. M. Seo, M. M. Pyle, M. Tamura, S. H. Bossmann and D. L. Troyer, A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model, Small, 2012, 8, 913–920.
E. Y. Snyder, D. L Deitcher, C. Walsh, S. Arnold-Aldea, E. A. Hartwieg and C. L. Cepko, Multipotent neural cell lines can engraft and participate in development of mouse cerebellum, Cell, 1992, 68, 33–51.
S. Mahor, E. Collin, B. C. Dash and A. Pandit, Controlled release of plasmid DNA from hyaluronan nanoparticles, Curr. Drug Delivery, 2011, 8, 354–362.
C. Doi, D. K. Maurya, M. M. Pyle, D. Troyer and M. Tamura, Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice, Cytotherapy, 2010, 12, 408–417.
D. K. Chatterjee, L. S. Fong and Y. Zhang, Nanoparticles in photodynamic therapy: an emerging paradigm, Adv. Drug Delivery Rev., 2008, 60, 1627–1637.
R. S. Rachakatla and D. Troyer, Wharton’s jelly stromal cells as potential delivery vehicles for cancer therapeutics, Future Oncol., 2009, 5, 1237–1244.
A. H. Cory, T. C. Owen, J. A. Barltrop and J. G. Cory, Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture, Cancer Commun., 1991, 3, 207–212.
M. Ishizuka, F. Abe, Y. Sano, K. Takahashi, K. Inoue, M. Nakajima, T. Kohda, N. Komatsu, S.-i. Ogura and T. Tanaka, Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy, Int. Immunopharmacol., 2011, 11, 358–365.
M. H. Bellini, E. L. Coutinho, L. C. Courrol, F. R. D. Silva, N. D. Vieira and N. Schor, Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma, J. Fluoresc., 2008, 18, 1163–1168.
K. Onizawa, N. Okamura, H. Saginoya and H. Yoshida, Characterization of autofluorescence in oral squamous cell carcinoma, Oral Oncol., 2003, 39, 150–156.
P. Krishnamurthy and J. D. Schuetz, The role of ABCG2 and ABCB6 in porphyrin metabolism and cell survival, Curr. Pharm. Biotechnol., 2011, 12, 647–655.
M. Gentile, L. Latonen and M. Laiho, Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses, Nucleic Acids Res., 2003, 31, 4779–4790.
S. Pop, R. Ion, M. Neagu and C. Constantin, Sensitizer localization and immune response in photodynamic therapy of B16 cells, Laser Phys., 2011, 21, 576–581.
J. Nowakowska, The effect of pH on the absorption spectra of porphyrins, Ann. Acad. Med. Gedan., 2002, 32, 281–292.
K. Berg, Basic principles of 5-aminolevulinic acid-based photodynamic therapy, Comprehensive Ser. Photosci., 2001, 2, 115–162.
G. Ren, Y. Pan and Z. Cheng, Molecular probes for malignant melanoma imaging, Curr. Pharm. Biotechnol., 2010, 11, 590–602.
M.-S. Kang, D.-M. Kim, J. S. Kim, J.-H. Jeong, Synthesis of 5-aminolevulinic acid (ALA) and its t-butyl ester for the fluorescence detection of early cancer, Arch. Pharmacal Res., 2005, 28, 1111–1113.
T. B. Shrestha, Heterocycles for Life-Sciences Applications and Information Storage, Department of Chemistry, Kansas State University, Manhattan, KS, 2010, p. 162.
K. Teranishi and O. Shimomura, Solubilizing coelenterazine in water with hydroxypropyl-beta-cyclodextrin, Biosci., Biotechnol., Biochem., 1997, 61, 1219–1220.
K. E. Mitchell, M. L. Weiss, B. M. Mitchell, P. Martin, D. Davis, L. Morales, B. Helwig, M. Beerenstrauch, K. Abou-Easa, T. Hildreth, D. Troyer and S. Medicetty, Matrix cells from Wharton’s jelly form neurons and glia, Stem Cells, 2003, 21, 50–60.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Electronic supplementary information (ESI) available: 1H-NMR of aminolevulinic acid, ANOVA analysis of the in vitro and in vitro PDT experiments. See DOI: 10.1039/c2pp05417e
Rights and permissions
About this article
Cite this article
Shrestha, T.B., Seo, G.M., Basel, M.T. et al. Stem cell-based photodynamic therapy. Photochem Photobiol Sci 11, 1251–1258 (2012). https://doi.org/10.1039/c2pp05417e
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c2pp05417e